This is a firm fixed-price purchase order contract awarded by the Department of the Army Medical Command to Phadia US Inc., a subsidiary of Thermo Fisher Scientific, for the delivery of $146,363.76 in allergen detection equipment and reagents. Phadia is a provider of allergy and autoimmune testing solutions, and has previously supplied allergy testing analyzers, reagents, and associated consumables to Department of Defense health agencies and facilities to support their medical readiness...
This is a firm-fixed-price BPA call order awarded by the U.S. Army Medical Command (MEDCOM) to Phadia US Inc., a subsidiary of Thermo Fisher Scientific. The contract, valued at $600,000.00, is for allergy and asthma testing products and services to support military medical readiness and research programs. Phadia has received multiple prime federal contracts from agencies such as the Defense Health Agency and Department of the Air Force for its proprietary IMMUNOCAP SYSTEM ANALYZERS and related...
This is a firm-fixed-price BPA call awarded by the U.S. Army Medical Command (MEDCOM) to Phadia US Inc., a subsidiary of Thermo Fisher Scientific, for $600,000.00. The contract is for the provision of immunodiagnostic analyzers, reagents, and consumables used for allergen and asthma testing to support military medical readiness and research programs. Phadia has received numerous prime federal contract awards from agencies like the Defense Health Agency and Department of the Air Force for its...
This firm-fixed-price Blanket Purchase Agreement (BPA) call was awarded by the U.S. Army Medical Command (MEDCOM) to Phadia US Inc., a subsidiary of Thermo Fisher Scientific Inc. The contract has a ceiling value of $600,000.00 and no set-aside designation. It provides for the procurement of immunodiagnostic analyzers, reagents, and consumables used for allergen and asthma testing to support military medical readiness and research programs. This contract is part of a larger BPA awarded by...
This is a firm-fixed-price Blanket Purchase Agreement (BPA) call order awarded by the U.S. Army Medical Command (MEDCOM) to Phadia US Inc., a subsidiary of Thermo Fisher Scientific, for $600,000.00. The BPA call is for allergy and asthma testing solutions, including analyzers, reagents, and consumables to support military medical readiness and research programs. Phadia US Inc. has been the sole source provider for many similar MEDCOM contracts due to its proprietary products being the only...
The Department of the Army Medical Command awarded a $892,500 firm fixed price purchase order to Phadia US Inc. Immunodiagnostics Division for autoimmune and allergy testing reagents with an analyzer. The prime contractor, Phadia US, is a division of Thermo Electron Corporation Financial Services. The contract has a period of performance from May 29, 2020 through May 31, 2025. The place of performance will be in Germany. This purchase order supports the Army Medical Command's mission to...
This is a firm-fixed-price BPA call issued by the U.S. Army Medical Command (MEDCOM) in Germany for the month of December 2016, awarded to Phadia US Inc., a subsidiary of Thermo Fisher Scientific. The contract, valued at $600,000.00, is for the procurement of Phadia's proprietary IMMUNOCAP SYSTEM ANALYZERS and related equipment, supplies, and technical support to support military medical readiness and research programs. Phadia has been the sole source provider for these types of allergy...
This is a firm-fixed-price Blanket Purchase Agreement (BPA) call awarded by the Defense Health Agency (DHA) to Phadia US Inc., a subsidiary of Thermo Fisher Scientific, for the supply of PHADIA IMMUNOCAP SPEC IGE diagnostic equipment, reagents, and related services. The contract has a ceiling value of $24,960.42 and a period of performance through September 30, 2025. Phadia US Inc. is a foreign-owned, for-profit organization that specializes in providing advanced allergy and autoimmune testing...
This federal contract award, valued at $154,070.40, was issued by the Medical Command (MEDCOM) division of the U.S. Department of Defense to Fisher Scientific Company L.L.C.'s Fisher Healthcare division. The contract is for the provision of immunoassay reagents and consumables, with an ultimate completion date of September 30, 2016. The contract is a firm fixed-price purchase order that was awarded without any set-aside designation. Fisher Scientific Company L.L.C. is a subsidiary of the...
This firm-fixed-price contract, awarded by the Defense Health Agency (DHA) to Fisher Scientific Company L.L.C., is for the delivery of two immunoanalyzers for allergy, thyroid antibody, and thyroid peroxidase testing, including equipment, consumables, reagents, training, and maintenance. The contract has a potential value of $2,405,617.92 and a period of performance from October 1, 2024 to September 30, 2027. The original solicitation was issued by the United States Army Health Contracting...